Home › Core › ISCC-IDs › 28C3cAM9bPipo

View ISCC-ID

Core Data

28C3cAM9bPipo
ISCC-ID - digital asset identifier
CCLTpr4SRYBGc-CT1PRbzzKrLYP-CDCtkHLhM9gfa-CRAC8WKetEwr7
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

compliance with guidelines and factors associated with ordering the 21gene breast cancer assay

Ledger Reference

coblo
Source Ledger/Blockchain
12400169
N-th ISCC Decleration on source ledger
7a92fc1403ade2fac5b846e00355e9f64deca6c44ef436da0b291484d379ea9c
Hash of block that includes the ISCC-DECLARATION
91711c08007fa41f387ecab45eba5b0df4d7003d538c43298919ee22d9bf8425
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Compliance with guidelines and factors associated with ordering the 21-gene breast cancer assay.", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Valentina I. Petkov", "@type": "Person"}, {"name": "Nadia Howlader", "@type": "Person"}, {"name": "Kathleen Cronin", "@type": "Person"}, {"name": "Allison W. Kurian", "@type": "Person"}, {"name": "Lynne Penberthy", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://pdfs.semanticscholar.org/761d/a5ed631f77d2f59bf8a04fae91dc8a38077f.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Society of Clinical Oncology (ASCO)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1200/jco.2016.34.15_suppl.6552", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLTpr4SRYBGc-CT1PRbzzKrLYP-CDCtkHLhM9gfa-CRAC8WKetEwr7", "propertyID": "ISCC"}], "datePublished": "2016-05-20"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close